WallStSmart
VNDA

Vanda Pharmaceuticals Inc

NASDAQ: VNDA · HEALTHCARE · BIOTECHNOLOGY

$7.10
+0.71% today

Updated 2026-04-30

Market cap
$411.32M
P/E ratio
P/S ratio
1.90x
EPS (TTM)
$-3.74
Dividend yield
52W range
$4 – $10
Volume
2.8M

Vanda Pharmaceuticals Inc (VNDA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-51.62M$-51.64M$-45.96M$169.34M$-10.90M$-28.41M$-44.92M$-39.59M$-81.55M$12.45M$-8.10M$-1.98M$29.99M$45.95M$51.77M$64.21M$31.98M$12.80M$-15.76M$-109.44M
Capital expenditures$1.35M$279433.00$943659.00$12.00M$0.00$275000.00$2.02M$176000.00$8.77M$2.53M$1.41M$1.66M$25.37M$1.02M$1.79M$552000.00$679000.00$383000.00$490000.00$998000.00
Depreciation
Stock-based comp$6.13B$19.62M$13.39M$11.23M$4.98M$5.50M$4.09M$4.60M$5.88M$7.96M$8.54M$10.46M$11.67M$13.46M$13.36M$15.37M$16.28M$14.04M$12.43M$9.47M
Free cash flow$-52.97M$-51.92M$-46.90M$157.34M$-10.90M$-28.68M$-46.93M$-39.77M$-90.32M$9.92M$-9.51M$-3.65M$4.62M$44.93M$49.98M$63.66M$31.30M$12.42M$-16.25M$-110.44M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$45.36M$849000.00$-24.01M$-3.86M$-10.06M$-10.42M$-6.80M$27.45M$-16.10M$15.91M$-8.93M$82.64M